InvestorsHub Logo
Followers 24
Posts 817
Boards Moderated 0
Alias Born 04/15/2007

Re: None

Wednesday, 01/29/2020 1:15:38 PM

Wednesday, January 29, 2020 1:15:38 PM

Post# of 82871
Dowling and Mackay met with FDA Jan. 16th.
Event Date: 01/16/2020
Location: Silver Spring, MD
Subject: Listening Session with the Cannabidiol (CBD) Coalition
FDA Participant/Group: ALISON THOMPSON; JOSEPH FRANKLIN; RACHEL OSTERMAN; CARA WELCH; LOWELL SCHILLER; SHARON MAYL; MICHAEL LEVY; MELISSA ROBB; CASSANDRA TAYLOR; DENNIS KEEFE; APRIL ALEXANDROW; STEVEN TAVE; REBECCA GOLDBERG; SHERENE SEPEHRI;
Non FDA Participant/Group: Brendan Carroll, Marc Scheineson (Alston & Bird LLP); Cynthia Bryant (Demetrix, Inc.); Bill Grubb (Noramco); Angelo Fefekos, Etan Bendheim, Jeremy Friedberg (LAVVAN, Inc.); Wendi Young (Mile High Labs); Josh Hoerner, Scott Warner (Purisys); Douglas “Duffy” McKay, Joseph Dowling (CV Sciences, Inc.); Trevor Peters (Willow Biosciences);
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVSI News